PLAY PODCASTS
An NJ biotech lab says it has a treatment for very sick COVID-19 patients. What happens next?

An NJ biotech lab says it has a treatment for very sick COVID-19 patients. What happens next?

Researchers at BioAegis in New Jersey have been studying a therapy for pneumonia patients that they say can help treat people with severe cases of COVID-19. It's a protein called gelsolin. Now they're trying to get it through the FDA approval process. Carol MacKenzie spoke with the Chief Medical Officer at BioAegis Therapeutics, Dr. Mark DiNubile, to find out what he's working on and why he thinks it can help COVID-19 patients. See omnystudio.com/policies/listener for privacy information.

The Week in Philly from KYW Newsradio

March 27, 202021m 33s

Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

Researchers at BioAegis in New Jersey have been studying a therapy for pneumonia patients that they say can help treat people with severe cases of COVID-19. It's a protein called gelsolin. Now they're trying to get it through the FDA approval process. Carol MacKenzie spoke with the Chief Medical Officer at BioAegis Therapeutics, Dr. Mark DiNubile, to find out what he's working on and why he thinks it can help COVID-19 patients.  See omnystudio.com/policies/listener for privacy information.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

← All episodes of The Week in Philly from KYW Newsradio